RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access
Peptide drugs are popular, but FDA scientists warn they're untested, may be harmful. O recorte ajuda a contextualizar a pauta dentro de Tech.
Notícias
Acompanhe as Notícias da Recifes
Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.
Bristol declared ‘city of harm reduction’ as Greens seek less punitive drug policy
Councillors pass motion that paves way to setting up drugs-consumption facility where users can be helped and treatedUK politics live – latest updatesBristol has been formally declared a “city of harm reduction”, with local politicians pledging to focus on helping and treating us
'Food noise' discussion on social media helps define the term
With the rise of weight-loss drugs such as GLP-1 medications in recent years, the phrase "food noise" has taken off, particularly in conversations about health and wellness on social media. While thinking about food during the day is normal, food noise is often used to describe e
Foundational research points to new therapeutic strategies for an emerging cancer drug
Pancreatic cancer is one of the deadliest cancers and the third-leading cause of cancer-related death in the United States. While scientists continue searching for new therapies, advances can also come from understanding how existing drugs work. By uncovering the underlying biolo
Gut-homing antibodies help protect against norovirus, paving path for new vaccines, therap
As the leading cause of viral gastroenteritis worldwide, norovirus is an all too familiar ailment. Its telltale digestive upset—not to mention its reputation for being notoriously contagious—has earned it the nicknames "winter vomiting bug" and "stomach flu." Yet despite millions
New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature Medicine.
Could psychedelic therapy have a place in end‑of‑life care? We asked doctors
The therapeutic use of psychedelic drugs has attracted no shortage of media and scientific interest in recent years—and this is only likely to grow.
Small-molecule antiviral drug targets ACE2 receptor to block coronaviruses from entering c
The ongoing evolution of SARS-CoV-2, particularly the rapid emergence of the omicron variant and its sublineages, has weakened the effectiveness of existing vaccines and antiviral drugs, underscoring the potential risk of future coronavirus pandemics. In response, a joint researc
Opposing protein pathways steer skin stem cells toward renewal or repair
Two proteins with opposing functions orchestrate the development and maintenance of healthy skin, Stanford Medicine researchers have found. Modulating their activity with topical drugs could reduce inflammation, aid wound healing and slow or halt the growth of skin cancer, the re
Existing drugs could be repurposed for longevity by tapping network of aging-related genes
The quest to prolong life has gone on for as long as human existence itself, from the mythical Fountain of Youth to quick-fix fads like intermittent fasting, supplements and injections. But if you take a look in your medicine cabinet, you may unwittingly come across a drug that h
New Alzheimer's drugs offer hope for some, but good dementia care protects the humanity of
Disease-modifying drugs for Alzheimer's offer a meaningful glimpse of hope for many people who fear dementia. Alzheimer's disease is the most common cause of dementia, but dementia itself is an umbrella term for symptoms such as memory loss, confusion and changes in thinking.
Cancer drug shortage renews calls for federal action
Cancer doctors across the United States are running short of essential generic chemotherapy drugs, and some fear the squeeze could force widespread rationing, The New York Times reported.